skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

32 Total results for product and free and sample content found

Pink Sheet

UK Gov't Disowns ‘Secret’ Meetings With US On Post-Brexit Drug Pricing

Brexit and the NHS are likely to be key issues as political parties in the UK prepare to campaign ahead of the general election in December. 

Topic Pharma-Brexit Reimbursement

Scrip

J.P. Morgan Conference Updates

JP_Morgan_Notebook_Day_1

Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.

Scrip

Novartis Sees Reimbursement Advantage For PCSK9 Launch

Analysis

Administration under the medical benefit/Medicare Part B could mean easier reimbursement. The company outlined early plans for the launch of inclisiran after announcing it will buy The Medicines Company for $9.7bn.

Topic Business Strategies Deal trends Reimbursement

Datamonitor Healthcare

Multiple Myeloma Pricing, Reimbursement, and Access

Multiple Myeloma Pricing, Reimbursement, and Access

Disease management and treatment programmes change, as research evolves and new discoveries are made. Your market access strategies must evolve too.

Topic Cancer Drug development landscape Reimbursement

Datamonitor Healthcare

Global Market Access Webinar

Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.

Topic Reimbursement

Datamonitor Healthcare

Market Access Data that makes sense

Market Access Data that makes sense

How can you find current quantitative and qualitative evidence that informs your market access strategy?

Topic Reimbursement

Pink Sheet

Goodbye CFDA, Hello MRA: China Overhauls Regulatory Bodies

Goodbye CFDA, Hello MRA: China Overhauls Regulatory Bodies

China proposes to merge its top drug regulator into new combined body, and creates a medical reimbursement agency in move viewed as sign of strengthening regulatory oversight.

Topic Reimbursement Drug review

Medtech Insight

NEST Coordinating Center At Year One: Device Data-Sharing Network In Its Sights

NEST Coordinating Center At Year One: Device Data-Sharing Network In Its Sights

A year after the NEST Coordinating Center was launched, the group has expanded its staff.

Topic Reimbursement

Medtech Insight

Lingering Debt And New E-Procurement System Await Turkish Medtech

Lingering Debt And New E-Procurement System Await Turkish Medtech

2017 saw developments that were beneficial to the Turkish medtech industry, like the continued progress of the billion-dollar City Hospitals project.

Topic Reimbursement

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: